SCHEMBL9610446

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL9610447	0.96	MEN1 (0.32)	HSD17B10KMT2AMEN1HPGDMAPT
	SCHEMBL2775387	0.92	POLB (0.35)	HSD17B10KMT2AMEN1HPGDMAPT
	SCHEMBL9610525	0.86	EDNRB (0.35)	HSD17B10KMT2AMEN1HPGDMAPT
	SCHEMBL9610301	0.86	POLB (0.36)	POLB
	SCHEMBL19335194	0.83	—	—
	SCHEMBL19335195	0.81	—	—
	SCHEMBL18354442	0.80	EDNRB (0.35)	HSD17B10MAPTALDH1A1ACHEPOLB
	SCHEMBL9610478	0.79	KDM4E (0.34)	HSD17B10MAPTALDH1A1CYP3A4ACHE
	SCHEMBL9610453	0.78	TAS1R3 (0.36)	HSD17B10KMT2AMEN1HPGDMAPT
	SCHEMBL19719109	0.76	—	—

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.